Drug
Upifitimab Rilsodotin
Upifitimab Rilsodotin: highest development phase Phase 3, developed by Mersana Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Mersana Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Upifitimab rilsodotin NCT05329545 | Phase 3 | High Grade Serous Ovarian Cancer |
Latest
No recent events.
Follow Upifitimab Rilsodotin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.